Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2010 | 2 |
2011 | 2 |
2012 | 1 |
2013 | 1 |
2019 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Novel targeted therapies for prostate cancer.
Urol Clin North Am. 2010 Feb;37(1):105-19, Table of Contents. doi: 10.1016/j.ucl.2009.11.011.
Urol Clin North Am. 2010.
PMID: 20152524
Review.
Lapatinib for breast cancer: a review of the current literature.
MacFarlane RJ, Gelmon KA.
MacFarlane RJ, et al.
Expert Opin Drug Saf. 2011 Jan;10(1):109-21. doi: 10.1517/14740338.2011.533168. Epub 2010 Nov 20.
Expert Opin Drug Saf. 2011.
PMID: 21091041
Review.
Item in Clipboard
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.
Bjarnason GA, Knox JJ, Kollmannsberger CK, Soulieres D, Ernst DS, Zalewski P, Canil CM, Winquist E, Hotte SJ, North SA, Heng DYC, Macfarlane RJ, Venner PM, Kapoor A, Hansen AR, Eigl BJ, Czaykowski P, Boyd B, Wang L, Basappa NS.
Bjarnason GA, et al.
Eur J Cancer. 2019 Feb;108:69-77. doi: 10.1016/j.ejca.2018.12.006. Epub 2019 Jan 14.
Eur J Cancer. 2019.
PMID: 30648632
Free article.
Clinical Trial.
Item in Clipboard
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.
Hotte SJ, Chi KN, Joshua AM, Tu D, Macfarlane RJ, Gregg RW, Ruether JD, Basappa NS, Finch D, Salim M, Winquist EW, Torri V, North S, Kollmannsberger C, Ellard SL, Eigl BJ, Tinker A, Allan AL, Beja K, Annala M, Powers J, Wyatt AW, Seymour L; Canadian Cancer Trials Group (formerly NCIC Clinical Trials Group).
Hotte SJ, et al. Among authors: macfarlane rj.
Clin Genitourin Cancer. 2019 Jun;17(3):201-208.e1. doi: 10.1016/j.clgc.2019.03.005. Epub 2019 Mar 15.
Clin Genitourin Cancer. 2019.
PMID: 31056399
Clinical Trial.
Item in Clipboard
Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer.
Watahiki A, Macfarlane RJ, Gleave ME, Crea F, Wang Y, Helgason CD, Chi KN.
Watahiki A, et al. Among authors: macfarlane rj.
Int J Mol Sci. 2013 Apr 10;14(4):7757-70. doi: 10.3390/ijms14047757.
Int J Mol Sci. 2013.
PMID: 23574937
Free PMC article.
Clinical Trial.
Item in Clipboard
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.
Selth LA, Townley S, Gillis JL, Ochnik AM, Murti K, Macfarlane RJ, Chi KN, Marshall VR, Tilley WD, Butler LM.
Selth LA, et al. Among authors: macfarlane rj.
Int J Cancer. 2012 Aug 1;131(3):652-61. doi: 10.1002/ijc.26405. Epub 2011 Nov 3.
Int J Cancer. 2012.
PMID: 22052531
Free article.
Item in Clipboard
Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis.
Macfarlane RJ, McCully BJ, Fernandez CV.
Macfarlane RJ, et al.
Pediatr Nephrol. 2004 Aug;19(8):924-7. doi: 10.1007/s00467-004-1524-y. Epub 2004 Jun 4.
Pediatr Nephrol. 2004.
PMID: 15179573
Item in Clipboard
Cite
Cite